Loading...

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

MDS - 824

Elritercept vs epoetin alfa in erythropoiesis-stimulating agent (ESA)-naοve adults with lower-risk myelodysplastic syndromes (MDS) and transfusion-dependent anemia: The ELRiSE MDS phase 3 study

Preview of Elritercept vs epoetin alfa in erythropoiesis-stimulating agent (ESA)-naοve adults with lower-risk myelodysplastic syndromes (MDS) and transfusion-dependent anemia: The ELRiSE MDS phase 3 study

View Poster Contact Presenter

Poster Presenter

Valeria Santini

Authors

Valeria Santini

Part of Topic

Myelodysplastic Syndromes (MDS)

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.